CTOs on the Move

Foundation for Care Management

www.fcmcme.org

 
Foundation for Care Management is a Vashon, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.fcmcme.org
  • 20114 77th Pl SW
    Vashon, WA USA 98070
  • Phone: 425.821.9917

Executives

Name Title Contact Details

Similar Companies

Government Scientific Source, Inc.

Government Scientific Source, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Reston, VA. To find more information about Government Scientific Source, Inc., please visit www.govsci.com

Beth Abraham Health Services

Beth Abraham Health Services is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Bronx, NY. To find more information about Beth Abraham Health Services, please visit www.bethabe.org

InComm Conferencing

InComm Conferencing is a Glen Rock, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Oklahoma Rsdntl Assisted Livng

Oklahoma Rsdntl Assisted Livng is a Oklahoma City, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Monarch Medical Technologies

Monarch Medical Technologies is a digital health company committed to helping hospitals and health systems deliver optimal glycemic management for critical care and non-critical care patients alike. Insulin dosing has always been a daunting and time-intensive task, but now that burnout and staffing constraints have reached record highs, never have the associated risks and challenges been more acute. Add the impacts of new CMS measures for hyperglycemia and hypoglycemia, and you have the perfect storm. Our FDA-cleared EndoTool® Glucose Management System is designed specifically to displace traditional manual methods of insulin dosing with an intuitive and easy-to-use software application that integrates seamlessly with your EMR. This pioneering clinical decision support platform offers both intravenous and subcutaneous modalities, and has been shown to safely and reliably achieve and maintain target glucose goals. Specialized features help clinicians address the complexities surrounding diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic nonketotic syndrome (HHS), gestational diabetes, kidney function, residual insulin, and presence of steroids.